Risk perception and sex behaviour in pregnancy and breastfeeding in high HIV prevalence settings: Programmatic implications for PrEP delivery
HIV acquisition during pregnancy and breastfeeding significantly contributes toward paediatric HIV infection; however, little is known about risk behaviours in HIV-uninfected pregnant and postpartum women.
Want to know more about how the use of hormonal contraceptives might impact acquisition of HIV? Do you have questions about how to communicate with audiences about linkages between hormonal contraceptive use and HIV? Get answers to your questions during Springboard’s next Live Question and Answer session!
In many settings with high HIV prevalence, fertility rates are also high and women spend a significant proportion of their reproductive years pregnant, postpartum, or breastfeeding. Some, but not all, studies have demonstrated significantly higher HIV incidence during pregnancy. Per sex act analyses contribute an understanding of the absolute and relative risks of HIV transmission, and can provide insight into whether increased risk during pregnancy and postpartum is attributable to biological or sexual behavior changes.
In March, Springboard's featured content will focus on hormonal contraception and HIV. Studies about the linkages between hormonal contraceptive use and HIV acquisition have produced conflicting results. The inconclusive results have led to questions about human rights and how best to communicate with potential audiences. During March, we invite you to share articles, resources, research, programs, or thoughts about hormonal contraception and HIV.
Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial
Background Evidence from observational studies suggests an increased risk of HIV acquisition among women using depot medroxyprogesterone acetate (DMPA) contraception.
The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls.
Greentree II: Violence against Women and Girls, and HIV - Report on a high-level consultation on the evidence and implications
This publication synthesizes the discussions and conclusions of a three-day expert consultation on the links between HIV and violence against women and girls (VAWG).
STRIVE convened the consultation with support from WHO, UNICEF, UNAIDS and the Greentree Foundation in order to: